Prognostic role of circulating tumor cells in patients with EGFR -mutated or ALK -rearranged non-small cell lung cancer

Targeted therapies in non-small cell lung cancer: a focus on ALK/ROS1 tyrosine kinase inhibitors

(2017) Assunta Sgambato et al.   Expert Review of Anticancer Therapy

Circulating tumor cells as a predictive biomarker in patients with small cell lung cancer undergoing chemotherapy

(2017) Charu Aggarwal et al.   LUNG CANCER

Circulating Tumor Cells Predict Prognosis Following Tyrosine Kinase Inhibitor Treatment in EGFR-Mutant Non-Small Cell Lung Cancer Patients

(2017) Baohong Yang et al.   ONCOLOGY RESEARCH

Prognostic significance of circulating tumor cells in non-small cell lung cancer patients undergoing chemotherapy

(2017) Bing Tong et al.   Oncotarget

The use of circulating tumor cells in guiding treatment decisions for patients with metastatic castration-resistant prostate cancer

(2016) Wendy Onstenk et al.   CANCER TREATMENT REVIEWS

Correlation between epidermal growth factor receptor tyrosine kinase inhibitor efficacy and circulating tumor cell levels in patients with advanced non-small cell lung cancer

(2016) Wenjie He et al.   OncoTargets and Therapy

Global cancer statistics, 2012

(2015) Lindsey A. Torre et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Prognostic value of circulating tumor cells in metastatic breast cancer: a systemic review and meta-analysis

(2015) Q. Lv et al.   Clinical & Translational Oncology

Relationship between circulating tumour cell count and prognosis following chemotherapy in patients with advanced non-small-cell lung cancer

(2015) Zixuan Zhang et al.   RESPIROLOGY

Management of advanced non-small cell lung cancers with known mutations or rearrangements: latest evidence and treatment approaches

(2015) Meghan Shea et al.   Therapeutic Advances in Respiratory Disease

Circulating Tumor Cells and Prognosis of Patients with Resectable Colorectal Liver Metastases or Widespread Metastatic Colorectal Cancer: A Meta-Analysis

(2013) Bas Groot Koerkamp et al.   ANNALS OF SURGICAL ONCOLOGY

Evaluation of Circulating Tumor Cells and Circulating Tumor DNA in Non-Small Cell Lung Cancer: Association with Clinical Endpoints in a Phase II Clinical Trial of Pertuzumab and Erlotinib

(2012) E. A. Punnoose et al.   CLINICAL CANCER RESEARCH

Relationship of Circulating Tumor Cells to the Effectiveness of Cytotoxic Chemotherapy in Patients With Metastatic Non-Small-Cell Lung Cancer

(2012) Takashi Hirose et al.   ONCOLOGY RESEARCH

Evaluation and Prognostic Significance of Circulating Tumor Cells in Patients With Non–Small-Cell Lung Cancer

(2011) Matthew G. Krebs et al.   JOURNAL OF CLINICAL ONCOLOGY

Analysis of Circulating Tumor Cells in Patients with Non-small Cell Lung Cancer Using Epithelial Marker-Dependent and -Independent Approaches

(2011) Matthew G. Krebs et al.   Journal of Thoracic Oncology